← Back to Search

Cancer Screening

Glaucoma Screening for Glaucoma (G-SEARCH Trial)

San Francisco, CA
N/A
Waitlist Available
Led By Yvonne Ou, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Black people aged 50 years or older
People with diabetes aged 50 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if using established tests like optical coherence tomography for glaucoma screening is better at detecting undiagnosed cases compared to just providing education or delaying intervention. Glaucoma

See full description
Who is the study for?
This trial is for Californians at risk of glaucoma who haven't been diagnosed yet. It's not clear what specific inclusion or exclusion criteria are, but typically participants would need to meet certain age and health requirements.Check my eligibility
What is being tested?
The study tests if screening with OCT, color fundus photography, and tonometry can detect glaucoma better than just giving out educational brochures. Participants will be randomly assigned to get screened or receive the brochure.See study design
What are the potential side effects?
There are usually no significant side effects associated with glaucoma screening tests like OCT, photography, or tonometry. However, some individuals might experience discomfort from bright lights or eye pressure during testing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am Black and 50 years old or older.
 show original
Select...
I am 50 or older with diabetes.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Cataract surgery
Eyeglasses
Quality of Life survey

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: ScreeningExperimental Treatment2 Interventions
Group II: EducationActive Control1 Intervention
Group III: Delayed EducationActive Control1 Intervention
The same as the Educational Brochure arm, but delivered at the conclusion of the study.

Find a Location

Closest Location:University of California, San Francisco· San Francisco, CA· 2111 miles

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,628 Previous Clinical Trials
19,026,892 Total Patients Enrolled
9 Trials studying Glaucoma
76,791 Patients Enrolled for Glaucoma
Centers for Disease Control and PreventionFED
896 Previous Clinical Trials
25,009,077 Total Patients Enrolled
6 Trials studying Glaucoma
5,494 Patients Enrolled for Glaucoma
Yvonne Ou, MDPrincipal InvestigatorUniversity of California, San Francisco
Jeremy D Keenan, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco
6 Previous Clinical Trials
360,959 Total Patients Enrolled
3 Trials studying Glaucoma
16,315 Patients Enrolled for Glaucoma
~1333 spots leftby Mar 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top